Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fitscha

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Progress in Clinical and Biological Research|January 1, 1987
Fibrinogen and liver function parameters during PGE1-therapyP Fitscha, D Hartl, B Tiso, et al.
Zeitschrift Fur Kardiologie|June 1, 1981
[Electrocardiographic changes during long-term monitoring in a case of cardiac rupture after myocardial infarction (author's transl)]B Tiso, P Fitscha, W Meisner, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 1, 1992
Postprandial hyperlipemia does not inhibit platelet aggregationS Bisovsky, H Richter, P Fitscha, et al.
Lancet (London, England)|December 15, 1984
Detection of aneurysms by gamma-camera imaging after injection of autologous labelled plateletsH Sinzinger, J O'Grady, P Fitscha, et al.
Thrombosis Research|June 15, 1988
Comparable effect of prostaglandin E1 in decreasing in vivo platelet deposition on human lesion sites after intravenous and intraarterial applicationH Sinzinger, J O'Grady, P Fitscha, et al.
Prostaglandins|January 1, 1996
Prostaglandin E1 decreases circulating endothelial cellsH Sinzinger, P Fitscha, H Kritz, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1986
Platelet half-life in comparison to other in-vivo platelet function parameters such as thromboxane B2, beta-thromboglobulin and platelet factor 4 in patients with atherosclerotic lesions with and without hyperlipoproteinemiaE Strobl-Jäger, P Fitscha, J Kaliman, et al.
Blood Pressure. Supplement|January 1, 1994
Influence of calcium antagonists on platelet function and vascular prostacyclin productionC Pirich, P Schmid, P Fitscha, et al.
Thrombosis Research|July 15, 1997
Platelet response during prostaglandin E1-therapy in patients with non-insulin-dependent diabetes mellitusH Kritz, A Oguogho, P Fitscha, et al.
Prostaglandins, Leukotrienes, and Medicine|August 1, 1987
Prostacyclin synthesis stimulating plasma factor in patients with peripheral vascular diseaseE Strobl-Jäger, P Fitscha, J Kaliman, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Progress in Clinical and Biological Research|January 1, 1987
Fibrinogen and liver function parameters during PGE1-therapyP Fitscha, D Hartl, B Tiso, et al.
Zeitschrift Fur Kardiologie|June 1, 1981
[Electrocardiographic changes during long-term monitoring in a case of cardiac rupture after myocardial infarction (author's transl)]B Tiso, P Fitscha, W Meisner, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 1, 1992
Postprandial hyperlipemia does not inhibit platelet aggregationS Bisovsky, H Richter, P Fitscha, et al.
Lancet (London, England)|December 15, 1984
Detection of aneurysms by gamma-camera imaging after injection of autologous labelled plateletsH Sinzinger, J O'Grady, P Fitscha, et al.
Thrombosis Research|June 15, 1988
Comparable effect of prostaglandin E1 in decreasing in vivo platelet deposition on human lesion sites after intravenous and intraarterial applicationH Sinzinger, J O'Grady, P Fitscha, et al.
Prostaglandins|January 1, 1996
Prostaglandin E1 decreases circulating endothelial cellsH Sinzinger, P Fitscha, H Kritz, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1986
Platelet half-life in comparison to other in-vivo platelet function parameters such as thromboxane B2, beta-thromboglobulin and platelet factor 4 in patients with atherosclerotic lesions with and without hyperlipoproteinemiaE Strobl-Jäger, P Fitscha, J Kaliman, et al.
Blood Pressure. Supplement|January 1, 1994
Influence of calcium antagonists on platelet function and vascular prostacyclin productionC Pirich, P Schmid, P Fitscha, et al.
Thrombosis Research|July 15, 1997
Platelet response during prostaglandin E1-therapy in patients with non-insulin-dependent diabetes mellitusH Kritz, A Oguogho, P Fitscha, et al.
Prostaglandins, Leukotrienes, and Medicine|August 1, 1987
Prostacyclin synthesis stimulating plasma factor in patients with peripheral vascular diseaseE Strobl-Jäger, P Fitscha, J Kaliman, et al.
Pageof 13